Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001438047 | SCV001640914 | likely benign | Retinoblastoma | 2019-11-19 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002258257 | SCV002530846 | likely benign | Hereditary cancer-predisposing syndrome | 2021-04-19 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002258257 | SCV005160482 | likely benign | Hereditary cancer-predisposing syndrome | 2024-05-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |